Target intelligence / Profile preview

Immunoglobulin lambda variable 3-31 (IGLV3-31)

Target
IGLV3-31
Molecular classification
Other (Immunoglobulin gene segment, pseudogene)
01

Overview

Immunoglobulin lambda variable 3-31 (IGLV3-31) is classified as a pseudogene in humans, representing a segment of the immunoglobulin lambda light chain variable region that is incapable of encoding a functional protein due to accumulated mutations or truncations[2][6]. Immunoglobulin variable regions generally contribute to antigen recognition and diversity in antibody molecules, but pseudogenes like IGLV3-31 do not produce active immunoglobulin chain components. As such, it does not function as a receptor or conventional therapeutic target, nor is it involved directly in immune response or associated disease mechanisms. Its main role is as part of the genomic architecture contributing to immunoglobulin gene evolution and diversification, but it is not used diagnostically or therapeutically[2][5][6].

Other names
IGLV331V2-22Pimmunoglobulin lambda variable 3-31 (pseudogene)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-31 (IGLV3-31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-31 (IGLV3-31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call